FDA Inspection 1006743 — Wim Robberecht, MD, PhD
The FDA completed an inspection of Wim Robberecht, MD, PhD on Mar 10, 2017 in Leuven. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 10, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Leuven (Belgium)
Additional Details
Clinical Investigator (CI)